Related Experiment Video
Updated: May 12, 2026

07:54
Analysis of AtHIRD11 Intrinsic Disorder and Binding Towards Metal Ions by Capillary Gel Electrophoresis and Affinity Capillary Electrophoresis
Published on: August 22, 2018
Structural, functional and molecular docking study to characterize GMI1 from Arabidopsis thaliana
Md Rezaul Islam1, Md Ismail Hosen, Aubhishek Zaman
1Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, 1000, Bangladesh. rezaul.nayeem@gmail.com
Interdisciplinary Sciences, Computational Life Sciences
|April 23, 2013
Summary
Researchers identified a potential Adenosine Tri Phosphate (ATP) binding site on the novel SMC-like protein GMI1 in Arabidopsis thaliana using in silico modeling. Purine Mononucleotide showed strong binding affinity, suggesting it could act as an agonist or antagonist for GMI1.
Area of Science:
- Molecular Biology
- Biochemistry
- Computational Biology
Background:
- GMI1 is an SMC-hinge domain-containing protein involved in DNA double-strand break repair.
- Understanding GMI1's interaction with small molecules is crucial for elucidating its mechanism of action.
Purpose of the Study:
- To hypothesize and computationally model the Adenosine Tri Phosphate (ATP) binding region of the novel SMC-like GMI1 protein in Arabidopsis thaliana.
- To identify potential small molecules that could interact with GMI1.
Main Methods:
- In silico modeling and analysis of GMI1 protein sequence.
- GMI1-ATP docking experiments.
- Docking of small molecules with structural similarity to ATP, including Purine Mononucleotide.
Main Results:
- Sequence analysis revealed conserved nucleotide-binding motifs (Walker A, Walker B, ABC signature) in GMI1.
- GMI1 exhibited significant binding affinity to ATP (-5.4 kcal/mol), confirmed by docking experiments.
- Purine Mononucleotide demonstrated the strongest binding affinity to the identified region, suggesting potential agonist/antagonist activity.
Conclusions:
- The study successfully identified a potential ATP binding site on GMI1 using computational methods.
- Purine Mononucleotide is a promising candidate for modulating GMI1 activity.
- Further in vitro validation is required to confirm these computational findings.
